Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors

Lei Zhang, Maria B. Hapon, Alicia A. Goyeneche, Rekha Srinivasan, Carlos D. Gamarra-Luques, Eduardo A. Callegari, Donis D. Drappeau, Erin J. Terpstra, Bo Pan, Jennifer R. Knapp, Jeremy Chien, Xuejun Wang, Kathleen M. Eyster, Carlos M. Telleria

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The synthetic steroid mifepristone blocks the growth of ovarian cancer cells, yet the mechanism driving such effect is not entirely understood. Unbiased genomic and proteomic screenings using ovarian cancer cell lines of different genetic backgrounds and sensitivities to platinum led to the identification of two key genes upregulated by mifepristone and involved in the unfolded protein response (UPR): the master chaperone of the endoplasmic reticulum (ER), glucose regulated protein (GRP) of 78 kDa, and the CCAAT/enhancer binding protein homologous transcription factor (CHOP). GRP78 and CHOP were upregulated by mifepristone in ovarian cancer cells regardless of p53 status and platinum sensitivity. Further studies revealed that the three UPR-associated pathways, PERK, IRE1α, and ATF6, were activated by mifepristone. Also, the synthetic steroid acutely increased mRNA translation rate, which, if prevented, abrogated the splicing of XBP1 mRNA, a non-translatable readout of IRE1α activation. Moreover, mifepristone increased LC3-II levels due to increased autophagic flux. When the autophagic–lysosomal pathway was inhibited with chloroquine, mifepristone was lethal to the cells. Lastly, doses of proteasome inhibitors that are inadequate to block the activity of the proteasomes, caused cell death when combined with mifepristone; this phenotype was accompanied by accumulation of poly-ubiquitinated proteins denoting proteasome inhibition. The stimulation by mifepristone of ER stress and autophagic flux offers a therapeutic opportunity for utilizing this compound to sensitize ovarian cancer cells to proteasome or lysosome inhibitors.

Original languageEnglish (US)
Pages (from-to)1099-1117
Number of pages19
JournalMolecular Oncology
Volume10
Issue number7
DOIs
StatePublished - Aug 1 2016

Fingerprint

Mifepristone
Protein Biosynthesis
Lysosomes
Ovarian Neoplasms
Proteins
Proteasome Endopeptidase Complex
Unfolded Protein Response
Platinum
Transcription Factor CHOP
Steroids
Ubiquitinated Proteins
CCAAT-Enhancer-Binding Proteins
Proteasome Inhibitors
Endoplasmic Reticulum Stress
Chloroquine
Endoplasmic Reticulum
Proteomics
Cell Death
Phenotype
Cell Line

Keywords

  • Autophagic flux
  • Bortezomib
  • Chloroquine
  • ER stress
  • Mifepristone
  • Ovarian cancer
  • Ubiquitin proteasome system
  • Unfolded protein response
  • mRNA translation

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cancer Research

Cite this

Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors. / Zhang, Lei; Hapon, Maria B.; Goyeneche, Alicia A.; Srinivasan, Rekha; Gamarra-Luques, Carlos D.; Callegari, Eduardo A.; Drappeau, Donis D.; Terpstra, Erin J.; Pan, Bo; Knapp, Jennifer R.; Chien, Jeremy; Wang, Xuejun; Eyster, Kathleen M.; Telleria, Carlos M.

In: Molecular Oncology, Vol. 10, No. 7, 01.08.2016, p. 1099-1117.

Research output: Contribution to journalArticle

Zhang, L, Hapon, MB, Goyeneche, AA, Srinivasan, R, Gamarra-Luques, CD, Callegari, EA, Drappeau, DD, Terpstra, EJ, Pan, B, Knapp, JR, Chien, J, Wang, X, Eyster, KM & Telleria, CM 2016, 'Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors', Molecular Oncology, vol. 10, no. 7, pp. 1099-1117. https://doi.org/10.1016/j.molonc.2016.05.001
Zhang, Lei ; Hapon, Maria B. ; Goyeneche, Alicia A. ; Srinivasan, Rekha ; Gamarra-Luques, Carlos D. ; Callegari, Eduardo A. ; Drappeau, Donis D. ; Terpstra, Erin J. ; Pan, Bo ; Knapp, Jennifer R. ; Chien, Jeremy ; Wang, Xuejun ; Eyster, Kathleen M. ; Telleria, Carlos M. / Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors. In: Molecular Oncology. 2016 ; Vol. 10, No. 7. pp. 1099-1117.
@article{214c6e518f114acdb6a4506eac333739,
title = "Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors",
abstract = "The synthetic steroid mifepristone blocks the growth of ovarian cancer cells, yet the mechanism driving such effect is not entirely understood. Unbiased genomic and proteomic screenings using ovarian cancer cell lines of different genetic backgrounds and sensitivities to platinum led to the identification of two key genes upregulated by mifepristone and involved in the unfolded protein response (UPR): the master chaperone of the endoplasmic reticulum (ER), glucose regulated protein (GRP) of 78 kDa, and the CCAAT/enhancer binding protein homologous transcription factor (CHOP). GRP78 and CHOP were upregulated by mifepristone in ovarian cancer cells regardless of p53 status and platinum sensitivity. Further studies revealed that the three UPR-associated pathways, PERK, IRE1α, and ATF6, were activated by mifepristone. Also, the synthetic steroid acutely increased mRNA translation rate, which, if prevented, abrogated the splicing of XBP1 mRNA, a non-translatable readout of IRE1α activation. Moreover, mifepristone increased LC3-II levels due to increased autophagic flux. When the autophagic–lysosomal pathway was inhibited with chloroquine, mifepristone was lethal to the cells. Lastly, doses of proteasome inhibitors that are inadequate to block the activity of the proteasomes, caused cell death when combined with mifepristone; this phenotype was accompanied by accumulation of poly-ubiquitinated proteins denoting proteasome inhibition. The stimulation by mifepristone of ER stress and autophagic flux offers a therapeutic opportunity for utilizing this compound to sensitize ovarian cancer cells to proteasome or lysosome inhibitors.",
keywords = "Autophagic flux, Bortezomib, Chloroquine, ER stress, Mifepristone, Ovarian cancer, Ubiquitin proteasome system, Unfolded protein response, mRNA translation",
author = "Lei Zhang and Hapon, {Maria B.} and Goyeneche, {Alicia A.} and Rekha Srinivasan and Gamarra-Luques, {Carlos D.} and Callegari, {Eduardo A.} and Drappeau, {Donis D.} and Terpstra, {Erin J.} and Bo Pan and Knapp, {Jennifer R.} and Jeremy Chien and Xuejun Wang and Eyster, {Kathleen M.} and Telleria, {Carlos M.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.molonc.2016.05.001",
language = "English (US)",
volume = "10",
pages = "1099--1117",
journal = "Molecular Oncology",
issn = "1574-7891",
publisher = "Elsevier",
number = "7",

}

TY - JOUR

T1 - Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors

AU - Zhang, Lei

AU - Hapon, Maria B.

AU - Goyeneche, Alicia A.

AU - Srinivasan, Rekha

AU - Gamarra-Luques, Carlos D.

AU - Callegari, Eduardo A.

AU - Drappeau, Donis D.

AU - Terpstra, Erin J.

AU - Pan, Bo

AU - Knapp, Jennifer R.

AU - Chien, Jeremy

AU - Wang, Xuejun

AU - Eyster, Kathleen M.

AU - Telleria, Carlos M.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - The synthetic steroid mifepristone blocks the growth of ovarian cancer cells, yet the mechanism driving such effect is not entirely understood. Unbiased genomic and proteomic screenings using ovarian cancer cell lines of different genetic backgrounds and sensitivities to platinum led to the identification of two key genes upregulated by mifepristone and involved in the unfolded protein response (UPR): the master chaperone of the endoplasmic reticulum (ER), glucose regulated protein (GRP) of 78 kDa, and the CCAAT/enhancer binding protein homologous transcription factor (CHOP). GRP78 and CHOP were upregulated by mifepristone in ovarian cancer cells regardless of p53 status and platinum sensitivity. Further studies revealed that the three UPR-associated pathways, PERK, IRE1α, and ATF6, were activated by mifepristone. Also, the synthetic steroid acutely increased mRNA translation rate, which, if prevented, abrogated the splicing of XBP1 mRNA, a non-translatable readout of IRE1α activation. Moreover, mifepristone increased LC3-II levels due to increased autophagic flux. When the autophagic–lysosomal pathway was inhibited with chloroquine, mifepristone was lethal to the cells. Lastly, doses of proteasome inhibitors that are inadequate to block the activity of the proteasomes, caused cell death when combined with mifepristone; this phenotype was accompanied by accumulation of poly-ubiquitinated proteins denoting proteasome inhibition. The stimulation by mifepristone of ER stress and autophagic flux offers a therapeutic opportunity for utilizing this compound to sensitize ovarian cancer cells to proteasome or lysosome inhibitors.

AB - The synthetic steroid mifepristone blocks the growth of ovarian cancer cells, yet the mechanism driving such effect is not entirely understood. Unbiased genomic and proteomic screenings using ovarian cancer cell lines of different genetic backgrounds and sensitivities to platinum led to the identification of two key genes upregulated by mifepristone and involved in the unfolded protein response (UPR): the master chaperone of the endoplasmic reticulum (ER), glucose regulated protein (GRP) of 78 kDa, and the CCAAT/enhancer binding protein homologous transcription factor (CHOP). GRP78 and CHOP were upregulated by mifepristone in ovarian cancer cells regardless of p53 status and platinum sensitivity. Further studies revealed that the three UPR-associated pathways, PERK, IRE1α, and ATF6, were activated by mifepristone. Also, the synthetic steroid acutely increased mRNA translation rate, which, if prevented, abrogated the splicing of XBP1 mRNA, a non-translatable readout of IRE1α activation. Moreover, mifepristone increased LC3-II levels due to increased autophagic flux. When the autophagic–lysosomal pathway was inhibited with chloroquine, mifepristone was lethal to the cells. Lastly, doses of proteasome inhibitors that are inadequate to block the activity of the proteasomes, caused cell death when combined with mifepristone; this phenotype was accompanied by accumulation of poly-ubiquitinated proteins denoting proteasome inhibition. The stimulation by mifepristone of ER stress and autophagic flux offers a therapeutic opportunity for utilizing this compound to sensitize ovarian cancer cells to proteasome or lysosome inhibitors.

KW - Autophagic flux

KW - Bortezomib

KW - Chloroquine

KW - ER stress

KW - Mifepristone

KW - Ovarian cancer

KW - Ubiquitin proteasome system

KW - Unfolded protein response

KW - mRNA translation

UR - http://www.scopus.com/inward/record.url?scp=84971667822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84971667822&partnerID=8YFLogxK

U2 - 10.1016/j.molonc.2016.05.001

DO - 10.1016/j.molonc.2016.05.001

M3 - Article

VL - 10

SP - 1099

EP - 1117

JO - Molecular Oncology

JF - Molecular Oncology

SN - 1574-7891

IS - 7

ER -